HSE - PCRS

Application Details

HSE Application ID

HSE100129

HTA Number

26040

HTA Link

https://www.ncpe.ie/depemokimab-exdensur-hta-id-26040/

Drug

depemokimab

Brand

Exdensur®

Applicant

GlaxoSmithKline

Indication Applied For

Indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control.

Application Date

20/08/2026

Marketing Authorisation Date

12/02/2026

Application Status

Awaiting Proposal from Applicant

29/10/2026

Applicant Meeting Held with CPU

29/10/2026

Full Health Technology Assessment Commissioned by HSE

10/09/2026

Rapid Review Completed

09/09/2026

Rapid Review Commissioned

21/08/2026

Pricing and Reimbursement Application Complete

20/08/2026

New Search